EPIMINDER
Based out of Melbourne, Australia, Epiminder is a medical technology company with a focus on epilepsy monitoring.
EPIMINDER
Industry:
Biotechnology Electronic Health Record (EHR) Health Care Medical Device Personal Health
Founded:
2017-01-01
Address:
Australia, Isabela, Philippines
Country:
Philippines
Website Url:
http://www.epiminder.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Euro GStatic Google Static Content 99Robots HFCM
Similar Organizations
Artes Medical
Artes Medical is a medical technology company focused on developing, manufacturing.
Official Site Inspections
http://www.epiminder.com Semrush global rank: 7.47 M Semrush visits lastest month: 482
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Epiminder"
Epiminder - Redefining Epilepsy Monitoring
Epiminder was founded in 2017 by Professor Mark Cook as a research collaboration between the Bionics Institute, the University of Melbourne, St Vincent's Hospital Melbourne and Cochlear. …See details»
Epiminder – Where freedom begins
This boy became Professor Mark Cook, a global expert in neurology, who created cutting edge epilepsy treatments for over 30 years. His research has now culminated into the Minder ® …See details»
About – Epiminder
Epiminder is driven by the desire to find a solution for those living with epilepsy, to give them a greater sense of control over their disease and free them from the significant limitations and …See details»
Epiminder - Crunchbase Company Profile & Funding
Organization. Epiminder . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Epiminder is located in Australia, Isabela, Philippines. …See details»
Epiminder - LinkedIn
Epiminder | 1,468 followers on LinkedIn. Epilepsy is a complex neurological condition affecting over 80 million people globally, with a significant part of the patient population not responding to ...See details»
Epiminder - Bionics Institute
The Epiminder device comprises an electrode array implanted under the scalp designed to record brain activity. Data collected by the implant is sent to a small processor placed behind the ear and transferred wirelessly to a phone app for …See details»
FDA grants Breakthrough approval for Epiminder’s Implantable …
1 day ago Epiminder’s FDA application was supported by data from the UMPIRE clinical trial, conducted in leading Australian hospitals between 2019 and 2023. The trial demonstrated …See details»
Epiminder 2025 Company Profile: Valuation, Funding
Epiminder General Information Description. Developer of monitoring devices designed to improve the management of epilepsy and seizure-related conditions. The company's devices offer a monitoring system designed to detect epileptic …See details»
Epiminder - Contacts, Employees, Board Members, Advisors
Based out of Melbourne, Australia, Epiminder is a medical technology company with a focus on epilepsy monitoring.See details»
Epiminder’s EEG system for epilepsy receives FDA authorisation
16 hours ago Epiminder noted that the Minder system addresses the limitations of existing EEG technologies by offering actionable diagnostic information, which is crucial for the …See details»
Epiminder Secures $25 Million Investment for Groundbreaking …
Oct 31, 2024 Epiminder, a pioneering medical device company dedicated to revolutionizing brain monitoring technology, has successfully raised $25 million in its latest funding round. This …See details»
FDA authorises Epiminder medical device for epilepsy developed …
FDA authorises Epiminder medical device for epilepsy developed in collaboration with the Bionics Institute . We are proud to share that Epiminder’s Minder® device for epilepsy, pioneered by …See details»
Cochlear-backed medtech Epiminder seeks $200m val in pre-IPO …
Oct 30, 2024 Epiminder has hired E &P Financial as sole lead manager to raise up to $25 million at $200 million-plus valuation, a fortnight after it resubmitted its FDA application with the …See details»
Cochlear-backed Epiminder targets 2025 IPO as FDA authorisation …
2 days ago Street Talk reported that Epiminder was looking for $25 million at a $200 million-plus valuation in October. This was later converted to a $10 million pre-IPO convertible note …See details»
Epiminder - Redefining Epilepsy Monitoring
The Minder System is an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. It is a prescription device indicated to acquire, transmit, and store …See details»
FDA Grants Authorization to Epiminder’s Implantable Continuous …
1 day ago The agency had previously designated Minder a breakthrough technology underscoring the importance of this innovation. The marketing authorization makes brings an …See details»
Epiminder announces 5-year milestone of long term continuous …
Nov 26, 2024 Epiminder said the 5-year milestone is essential in the evolving paradigm of EEG monitoring for drug-resistant epilepsy patients and could open a path to seizure freedom. CEO …See details»
Cochlear backs Epiminder capital raising - Australian …
Medical device innovator Epiminder has raised $18 million in bridging funding to support the development of its lead product Minder, which aims to revolutionise the lives of millions of …See details»
Cochlear-backed Epiminder raises $16m to expand epilepsy …
Mar 15, 2022 Epiminder raised $10 million in initial investment prior to the commencement of its Phase I trial, which took place in St Vincent’s Hospital Melbourne in 2019. In late 2020, …See details»
The Epi-minder - YouTube
Mar 1, 2020 A team led by St Vincent’s Director of Neurology Professor Mark Cook collaborated with the Bionics Institute to create the Epi-minder – an epilepsy managemen...See details»